From boric-acid antifungal assays to spiroborate research.
The boron research began before the formal CSIRO Honours appointment. In 2015, Peter Duggan offered previously prepared antifungal compounds and help establishing assay protocols for an anticipated Honours project. The programme subsequently involved substantial experimental work assessing boric acid as an antifungal with Professor Ian Macreadie at RMIT, alongside synthesis and characterisation of boron-containing spiroborates at CSIRO Manufacturing, Clayton.
Boron research from the pre-Honours period · founder reports about 12 months of boric-acid laboratory assaysPeter Duggan's introduction came before the CSIRO Honours appointment.
A letter from Peter Duggan dated 29 October, preserved in the founder's November 2015 correspondence, discusses providing previously prepared compounds to establish fungicide protocols and setting aside laboratory space for Honours. The founder recalls Duggan also introducing the initial research subject and scientific publication; the exact title of that first paper remains to be confirmed.
The founder's 26 May 2016 Honours theory dissertation, supervised by Trevor Rook, examined tavaborole (AN2690), a boron-containing antifungal, its mechanism, activity and synthesis. In April 2017 he wrote that he would work with Professor Ian Macreadie on compounds Peter had supplied. In November 2017, Peter offered additional samples for testing in Ian's laboratory.
Approximately 12 months of boric-acid antifungal experiments: The founder describes a sustained period of laboratory assays examining the growth-inhibitory effects of boric acid. Contemporary correspondence corroborates laboratory experimentation and controls: in January 2018, new samples were to be tested using existing boric-acid methods; June 2018 messages discuss antifungal inhibition assays; August and September 2018 messages describe boric-acid tests, experimental responses to ribose and tryptophan, and continuing interpretation with Professor Macreadie. Exact dates delimiting the reported 12-month period have not been independently established.
The boric-acid investigations and later CSIRO spiroborate chemistry are related but should be recorded as distinct experimental contributions, not collapsed into one generic project. Subsequent review publication does not itself publish all the original assay results.
A research programme supported by contemporary correspondence.
The original correspondence distinguishes the initial industrial traineeship from the later postgraduate studentship. It does not establish three uninterrupted years of paid CSIRO employment.
Industrial traineeship
CSIRO recruitment correspondence from February 2018 records the founder's statement that he began industrial training with Peter Duggan in 2016. A separate April 2016 email refers to his CSIRO office contact.
Research contact maintained
The 2018 return correspondence records a year of absence in 2017. November 2017 emails show Peter Duggan reserving laboratory space and setting aside compounds for antifungal testing.
CSIRO student affiliate
A CSIRO postgraduate studentship offer was issued on 6 February 2018. November 2018 CSIRO correspondence confirms the affiliate's final recorded appointment date was 30 November 2018.
Appointment accuracy: The documented positions are described as an industrial traineeship and subsequent postgraduate studentship/affiliate engagement. The record supports work across 2016–2018, with an interruption in 2017; it does not justify calling the whole period continuous employment.
Compounds made, measured and assessed.
Three spiroborate products
In a laboratory update of 10 May 2018, the founder reported preparing three pure spiroborate compounds and working toward a further compound for subsequent assays. Subsequent messages discuss characterisation and ongoing synthetic work.
Antifungal activity
July 2018 correspondence with Peter Duggan records measured inhibitory responses, control plots and assay discussions involving Candida albicans and Candida krusei, including consideration of fluconazole as a comparator.
Extended antifungal assay programme
Alongside assays of compounds supplied or prepared at CSIRO, Costa investigated boric-acid inhibition in yeast and other fungal-model research with Professor Ian Macreadie. The founder reports approximately one year of experimental work; emails from 2018 document repeat assays, controls and interpretation of ribose- and tryptophan-associated responses.
The available messages confirm the research activities, but numerical potency claims should be assessed against the original assay records and controls before being presented as validated comparative results.
Evidence rather than unsupported biography.
Peter offered existing compounds for fungicide-assay method development and potential laboratory space for the anticipated Honours placement. The email was retained as an attachment in November 2015.
The founder prepared a dissertation examining the boron-containing antifungal tavaborole (AN2690) and its proposed mechanism of action.
The founder advised Peter he would work with Professor Macreadie on the supplied compounds; both researchers congratulated him on his academic results.
Plans for testing additional samples refer explicitly to earlier boric-acid assays.
Correspondence acknowledges the previous 2016 traineeship and the renewed postgraduate offer; the formal offer was sent on 6 February 2018.
Experimental progress reported to an RMIT collaborator: synthesis of three pure products for further analysis.
Emails document further antifungal assays, boric-acid inhibition experiments, and the study of potential biochemical explanations involving ribose and tryptophan. Interpretations remained hypotheses requiring appropriate controls and validation.
Emails titled “IC 50 values for spiroborates” provide the context for control plots, organism sensitivity and three tested compounds.
Discussion of compound characterisation and the remaining research work; clarification of affiliate appointment arrangements.
Formal cessation notice identifies 30 November 2018 as the final day of the appointment.
Publication distinction: The founder later co-authored the peer-reviewed review Mechanism of Action of Potent Boron-Containing Antifungals (2020) with Trevor Rook and Ian Macreadie. That publication documents related scientific interests, but it is a review article; it should not be presented as a peer-reviewed original report of the CSIRO spiroborate assay data. See the verified publications →